Brand Name	:	Montilab 10mg
Generic Name	:	Montilukest
Price	:	BDT: 15.00
Therapeutic Class	:	Others
Section	:	Other
Dosages	:	Prophylaxis of Asthma: Adults and Children (over 15 years): 10 mg once daily in the evening. Children (6 years-15 years): 5 mg once daily in the evening. Children (6 months-6 years): 4 mg once daily in the evening. Seasonal Allergic Rhinitis: Adults
Indication	:	Montelukast is indicated for the prophylaxis and chronic treatment of asthma. It is also indicated for the relief of seasonal allergic rhinitis in adults and pediatric patients and exercise induced bronchoconstriction.

Product Details

Composition : 

Montilab 10mg Tablet: Each film coated tablet contains Montelukast 10 mg  as Montelukast Sodium  USP.

Montilab 5mg Tablet: Each film coated tablet contains Montelukast 5 mg  as Montelukast Sodium  USP.

Montilab 4mg Tablet: Each film coated tablet contains Montelukast 4 mg  as Montelukast Sodium  USP.

Description :

Montelukast is a selective and orally active leukotriene receptor  antagonist that specifically inhibits cysteinyl leukotriene receptor.

Side effects :

Montelukast appears to be well tolerated. The most common adverse effects reported are headache, rash, dyspepsia, dizziness, edema, tremor, suicidal thoughts and abdominal pain.

Pregnancy: Montelukast has been assigned to pregnancy category B. It should be used during pregnancy only if clearly needed.

Lactation: It is not known if Montelukast  is excreted in human milk.

Pediatric use: Montelukast has been studied in pediatric patients (2 to 14 years of age). Studies have  shown that Montelukast does not affect the  growth rate of pediatric patients.

Contraindications :

Hypersensitivity to Montelukast or any component of this product.

Precautions :

Do not prescribe Montelukast to treat an acute asthma attack. Patients with known aspirin sensitivity should continue to avoid aspirin or NSAID agents while taking Montelukast.

Drug Interaction :

Montelukast may be administered with therapies routinely used in the prophylaxis and chronic treatment of asthma. In drug interaction studies, the recommended clinical dose of Montelukast did not have clinically important effects on the following  medicinal  products:  theophylline,  prednisone,  prednisolone,  oral contraceptives, terfenadine, digoxin and warfarin. Caution should be exercised, particularly in children, when Montelukast is co-administered with phenytoin, phenobarbital and rifampicin.

Storage :

Store in a cool and dry place, away from light. Keep out of the reach of children.